Zhong Chongke, Lv Liying, Liu Changjiang, Zhao Liang, Zhou Mo, Sun Wenjie, Xu Tan, Tong Weijun
Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu, China.
Department of Neurology, Xinganmeng People's Hospital, Xinganmeng, Inner Mongolia, China.
PLoS One. 2014 Sep 29;9(9):e107498. doi: 10.1371/journal.pone.0107498. eCollection 2014.
To assess the association between plasma homocysteine (Hcy), blood pressure (BP) and poor outcome at hospital discharge among acute ischemic stroke patients, and if high Hcy increases the risk of poor outcome based on high BP status in a northern Chinese population.
Between June 1, 2009 and May 31, 2013, a total of 3695 acute ischemic stroke patients were recruited from three hospitals in northern Chinese cities. Demographic characteristics, lifestyle risk factors, medical history, and other clinical characteristics were recorded for all subjects. Poor outcome was defined as a discharge modified Rankin Scale (mRS) score ≥3 or death. The association between homocysteine concentration, admission blood pressure, and risk of poor outcome following acute ischemic stroke was analyzed by using multivariate non-conditional logistic regression models.
Compared with those in the lowest quartile of Hcy concentration in a multivariate-adjusted model, those in the highest quartile of Hcy concentration had increased risk of poor outcome after acute ischemic stroke, (OR = 1.33, P<0.05). The dose-response relationship between Hcy concentration and risk of poor outcome was statistically significant (p-value for trend = 0.027). High BP was significantly associated with poor outcome following acute ischemic stroke (adjusted OR = 1.44, 95%CI, 1.19-1.74). Compared with non-high BP with nhHcy, in a multivariate-adjusted model, the ORs (95% CI) of non-high BP with hHcy, high BP with nhHcy, and high BP with hHcy to poor outcome were 1.14 (0.85-1.53), 1.37 (1.03-1.84) and 1.70 (1.29-2.34), respectively.
The present study suggested that high plasma Hcy and blood pressure were independent risk factors for prognosis of acute ischemic stroke, and hHcy may further increase the risk of poor outcome among patients with high blood pressure. Additionally, the results indicate that high Hcy with high BP may cause increased susceptibility to poor outcome among acute ischemic stroke patients in a northern Chinese population.
评估急性缺血性脑卒中患者血浆同型半胱氨酸(Hcy)、血压(BP)与出院时不良预后之间的关联,以及在中国北方人群中,基于高血压状态,高Hcy是否会增加不良预后的风险。
2009年6月1日至2013年5月31日期间,从中国北方城市的三家医院招募了3695例急性缺血性脑卒中患者。记录了所有受试者的人口统计学特征、生活方式风险因素、病史和其他临床特征。不良预后定义为出院时改良Rankin量表(mRS)评分≥3或死亡。采用多因素非条件logistic回归模型分析同型半胱氨酸浓度、入院血压与急性缺血性脑卒中后不良预后风险之间的关联。
在多因素调整模型中,与Hcy浓度处于最低四分位数的患者相比,Hcy浓度处于最高四分位数的患者急性缺血性脑卒中后不良预后风险增加(OR = 1.33,P < 0.05)。Hcy浓度与不良预后风险之间的剂量反应关系具有统计学意义(趋势p值 = 0.027)。高血压与急性缺血性脑卒中后不良预后显著相关(调整后OR = 1.44,95%CI,1.19 - 1.74)。在多因素调整模型中,与非高血压合并非高Hcy相比,非高血压合并高Hcy、高血压合并非高Hcy以及高血压合并高Hcy导致不良预后的OR(95%CI)分别为1.14(0.85 - 1.53)、1.37(1.03 - 1.84)和1.70(1.29 - 2.34)。
本研究表明,高血浆Hcy和血压是急性缺血性脑卒中预后的独立危险因素,高Hcy可能会进一步增加高血压患者不良预后的风险。此外,结果表明,在中国北方人群中,高Hcy合并高血压可能会导致急性缺血性脑卒中患者不良预后的易感性增加。